Cafepharma Today

May 28 2025 - GLP-1 prescriptions for weight loss soar, despite obstacles
GLP-1 prescriptions for weight loss soar, despite obstacles
FDA approves use of Sanofi's meningococcal vaccine in infants
GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win
AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Antidepressant Maker Euthymics Bioscience Taps $24 Million
NY Times, NY
Friday, July 23, 2010 - 9:14am
tags:
Euthymics Bioscience, antidepressants, venture capital
Cialis' success fuels Lilly push for new men's health drugs
Indianapolis Star, IN
Friday, July 23, 2010 - 8:33am
tags:
Eli Lilly, Cialis, enlarged prostate, testosterone, Acrux, Axiron
Times Are A-Changing and Tough, Says Roche
InVivo
Friday, July 23, 2010 - 7:28am
tags:
Roche, Severin Schwan, Pharma CEOs
Biotech Stock Mailbag: Exact Sciences
TheStreet.com
Friday, July 23, 2010 - 7:16am
tags:
EXACT Sciences, MannKind, Gilead Sciences, Somaxon, JNJ, Allos, Cell Therapeutics
Impax Labs Opana ER Gets Final FDA Approval
Pharmaceutical Business Review
Friday, July 23, 2010 - 7:00am
tags:
Impax Labs, Opana ER, FDA, painkillers
FTC Denies Abusing Power In Watson Investigation
Pharmalot
Friday, July 23, 2010 - 6:57am
tags:
FTC, Watson Pharmaceuticals, Provigil, Apotex, generics, Cephalon
Tibotec unveils results of experimental HIV drug
Fierce Biotech
Friday, July 23, 2010 - 6:41am
tags:
Tibotec, HIV, JNJ, rilpivirine
Human Genome Sciences revenue rises
Bizjournals.com
Friday, July 23, 2010 - 6:40am
tags:
earnings, Human Genome Sciences
The Value of an SPA for Avanir Pharmaceuticals
Seeking Alpha
Friday, July 23, 2010 - 6:38am
tags:
Vivus, SPA, Avanir
Reports of Psychotic Violence on Anti-Smoking Drug Chantix Pile Up But Pfizer Isn't Seeing Them
BNET Pharma
Friday, July 23, 2010 - 6:36am
tags:
smoking cessation, Pfizer, Chantix
Why I Bought Call Options on Mylan
Seeking Alpha
Friday, July 23, 2010 - 6:34am
tags:
Mylan, Eli Lilly, JNJ, Bristol-Myers Squibb, Teva Pharmaceuticals, generics
Elan's Loss Widens After Setting Aside $206 Million in U.S. for Zonegran
Bloomberg
Thursday, July 22, 2010 - 5:30pm
tags:
Elan, earnings
Drugmaker Actavis agrees debt refinancing deal
Reuters
Thursday, July 22, 2010 - 5:29pm
tags:
Actavis, debt refinancing
Repros begins Proellex study, shares spike
Bizjournals.com
Thursday, July 22, 2010 - 5:27pm
tags:
Proellex, Repros Therapeutics, endometriosis, uterine fibroids, fibroids
How Brand-Name Drugmakers Fight Generics
Pharmalot
Thursday, July 22, 2010 - 3:54pm
tags:
generics
A Sign of More Good Things to Come for Abbott
Motley Fool
Thursday, July 22, 2010 - 3:52pm
tags:
Abbott Laboratories
AstraZeneca Said to Pay $2 Million in Seroquel Cases
Bloomberg Businessweek
Thursday, July 22, 2010 - 3:51pm
tags:
settlements, AstraZeneca, antipsychotics, Seroquel
It's All About the Future for Amylin
Motley Fool
Thursday, July 22, 2010 - 3:49pm
tags:
Amylin, Bydureon, Byetta, diabetes, Novo Nordisk, Victoza, Merck, Januvia, Takeda, Actos, Onglyza, AstraZeneca
FDA asks NicOx for new naproxcinod trial
Fierce Biotech
Thursday, July 22, 2010 - 10:01am
tags:
FDA, NicOx, naproxcinod, osteoarthritis
What Investors Think About NeurogesX
Motley Fool
Thursday, July 22, 2010 - 9:59am
tags:
investors, NeurogesX

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.